VBIO

Valion Bio, Inc. Common Stock

2.49

USD

+0.11

+4.62%

Sep 22, 15:59 UTC -4

Closed

Pre-Market

2.61

+0.12

+4.66%

Valion Bio, Inc. Common Stock Profile

About

Valion Bio Inc. is a late-stage immunotherapeutics company. It offers Entolimod, which is a drug used to treat acute radiation syndrome. Valion Bio Inc., formerly known as Tivic Health Systems Inc., is based in SAN ANTONIO, United States.

Info & Links

CEO

Michael K. Handley

Headquarters

1305 E. Houston Street, Building 1, Suite 311
San Antonio, TX 78205, UNITED STATES

Auditor

Rosenberg Rich Baker Berman, P.A.

Share holders

Employees

Valion Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

2.31M

Enterprise Value

7.59M

Enterprise Value/EBITDA(ttm)

-0.51

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

0.08

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-24.83%

Operating Margin(ttm)

Profit Margin(ttm)

-444.52%

Return on Equity(ttm)

-193.17%

Return on Invested Capital(ttm)

-115.18%

Return on Assets(ttm)

-67.10%

Income Statement

Revenue(ttm)

146.00K

Revenue Per Share(ttm)

0.16

Gross Profit(ttm)

-145.00K

EBITDA(ttm)³

-14.93M

Net Income Available to Common(ttm)

-19.41M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

1.79

52-Week Change

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

887.59K

Dividend Yield

0.00%

Float⁴

866.00K

% Held by Insiders

2.50%

% Held by Institutions

4.25%

Balance Sheet

Total Cash(mrq)

2.11M

Total Cash Per Share(mrq)

2.37

Total Debt(mrq)

7.39M

Total Debt/Equity(mrq)

62.16%

Current Ratio(mrq)

1.11%

Quick Ratio(mrq)

0.86%

Book Value Per Share(mrq)

71.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-76.12

Free Cash Flow(ytd)

-10.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.